Watchlist Price Alert

Accolade Inc. (ACCD)

NASDAQ: ACCD · Real-Time Price · USD

7.02

0.00 (0.00%)

At close: Apr 07, 2025, 3:59 PM

0.00% (1D)

Bid	7.01
Market Cap	575.59M
Revenue (ttm)	446.72M
Net Income (ttm)	-180.3M
EPS (ttm)	-2.28
PE Ratio (ttm)	-3.08
Forward PE	n/a
Analyst	Hold

Ask	7.03
Volume	4,543,947
Avg. Volume (20D)	1,565,611
Open	7.02
Previous Close	7.02
Day's Range	7.02 - 7.02
52-Week Range	3.08 - 9.67
Beta	2.10

About ACCD

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ACCD

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ACCD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Accolade Inc. is scheduled to release its earnings on May 6, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

4 months ago

+104.78%

Accolate shares are trading higher after the compa... Unlock content with Pro Subscription

7 months ago

+5.87%

Accolade shares are trading higher. Needham reiterated a Buy rating on the stock and maintained a price target of $8.

News

1 month ago · cnbc.com

Digital health startup Transcarent takes Accolade private in $621 million deal

Transcarent on Tuesday announced it has completed its $621 million acquisition of Accolade. Accolade shareholders received $7.03 per share in cash, and the company will no longer be listed on the Nasd...

1 month ago · businesswire.com

Transcarent Completes Merger With Accolade

SAN FRANCISCO & SEATTLE--(BUSINESS WIRE)-- #HealthWayFinding--Today Transcarent announced the successful completion of its merger with Accolade, the leading health advocacy, expert medical opinion, an...

2 months ago · zacks.com

Has Accolade (ACCD) Outpaced Other Business Services Stocks This Year?

Here is how Accolade (ACCD) and Casella (CWST) have performed compared to their sector so far this year.

2 months ago · businesswire.com

ACCD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Accolade, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Accolade, Inc. (NASDAQ: ACCD) to Transcarent for $7.03 per share in cash is fair to Accol...